Somatropin (HGH) 16.7 mg / 50 IU

Biochem Somatropin (HGH) 16.7 mg / 50 IU – Recombinant Human Growth Hormone

Biochem Somatropin 16.7 mg / 50 IU is a formulation labeled as containing somatropin, a recombinant form of human growth hormone (HGH). Somatropin is a protein hormone designed to reproduce the biological activity of naturally occurring human growth hormone, which is produced and secreted by the anterior pituitary gland.

Somatropin belongs to the class of recombinant human growth hormone preparations. It consists of a single polypeptide chain containing 191 amino acid residues and has the same amino acid sequence as the predominant form of endogenous human growth hormone.

Human growth hormone plays an important role in regulating linear growth, protein metabolism, lipid metabolism, body composition, and numerous physiological processes associated with tissue development and maintenance.

Growth hormone secretion is controlled by the hypothalamic-pituitary axis through the coordinated activity of growth hormone-releasing hormone (GHRH), somatostatin, and other endocrine signals. Naturally occurring growth hormone is released in pulses, with secretion influenced by sleep, age, nutritional status, exercise, and metabolic conditions.

Unlike growth hormone-releasing peptides such as sermorelin, which stimulate the pituitary gland to release endogenous growth hormone, somatropin provides the growth hormone molecule directly. Its biological activity therefore does not depend on the pituitary gland's ability to produce sufficient endogenous growth hormone.

Somatropin acts primarily through the growth hormone receptor (GHR), a cell-surface receptor associated with the Janus kinase 2 (JAK2) and signal transducer and activator of transcription (STAT) signaling pathways. Receptor activation influences gene expression and metabolic processes in several tissues.

An important downstream effect of growth hormone receptor activation is the stimulation of insulin-like growth factor-1 (IGF-1) production. IGF-1 participates in growth-related signaling and mediates several anabolic and tissue-development effects associated with growth hormone.

Pharmaceutical somatropin has established clinical applications in specific growth hormone deficiency disorders and other defined medical conditions. These applications depend on the patient's diagnosis, age, clinical characteristics, and the indications authorized for the particular pharmaceutical product.

The Biochem Somatropin formulation contains a labeled quantity of 16.7 mg / 50 IU per vial. The two values describe approximately equivalent quantities of somatropin using the conventional conversion of 1 mg to approximately 3 IU. This is the total labeled vial content, not an individual administration amount.

The precise excipients, physical presentation, biological potency, and manufacturing specifications of the Biochem preparation have not been independently verified.

1. Activates Growth Hormone Receptors

Somatropin binds to growth hormone receptors expressed in tissues including the liver, skeletal muscle, adipose tissue, bone, and other organs.

Receptor activation initiates intracellular signaling involved in growth, metabolism, and tissue maintenance.

2. Stimulates Insulin-Like Growth Factor-1 Production

Growth hormone receptor activation stimulates IGF-1 production, particularly in the liver.

IGF-1 acts through its own receptor and contributes to cellular growth, tissue development, and several physiological effects associated with the growth hormone endocrine system.

3. Influences Protein Metabolism

Growth hormone participates in protein metabolism by influencing amino acid utilization and protein synthesis.

These physiological effects contribute to normal growth and tissue maintenance. However, changes in lean body mass do not necessarily translate into improved muscle strength or athletic performance.

4. Influences Lipid Metabolism

Somatropin can stimulate lipolysis and alter the utilization of stored fat as an energy source.

These effects are part of growth hormone's normal metabolic activity and may contribute to changes in body composition in patients receiving medically indicated growth hormone replacement.

5. Supports Normal Bone and Skeletal Growth

Growth hormone and IGF-1 are important regulators of longitudinal bone growth during childhood and adolescence.

Their activity contributes to growth plate function, skeletal development, and bone metabolism. Somatropin has established clinical applications in selected pediatric growth disorders.

6. Influences Carbohydrate Metabolism

Growth hormone participates in glucose regulation and can reduce insulin sensitivity.

Somatropin may increase blood glucose concentrations, particularly in susceptible individuals, making glucose metabolism an important consideration when evaluating its endocrine effects.

7. Has Established Applications in Growth Hormone Deficiency

Pharmaceutical somatropin is used to treat appropriately diagnosed growth hormone deficiency and certain other defined conditions.

Clinical benefits depend on the diagnosis and may include improvements in growth velocity in children or selected metabolic and body-composition measures in adults with confirmed deficiency.

These established effects should not be generalized to healthy individuals or to independently unverified somatropin preparations.

Somatropin's biological activity depends on receptor responsiveness, systemic exposure, formulation quality, and individual endocrine characteristics.

Clinically important adverse effects can include fluid retention, peripheral edema, joint discomfort, muscle pain, carpal tunnel symptoms, insulin resistance, and increased blood glucose. Additional risks include intracranial hypertension and complications in certain patients with underlying medical conditions. Growth hormone treatment also requires particular caution in people with active malignancy and is contraindicated in certain acute critical illnesses.

Somatropin is a recombinant protein hormone that directly activates growth hormone receptors rather than stimulating hypothalamic or pituitary release of endogenous growth hormone.

Step 1 – Introduction Into the Biological System

Somatropin enters the biological environment according to its formulation and route of administration.

Established pharmaceutical preparations are commonly administered by subcutaneous injection, although formulation characteristics vary. The administration characteristics of Biochem Somatropin 16.7 mg / 50 IU have not been confirmed.

Step 2 – Growth Hormone Receptor Binding

Somatropin binds to growth hormone receptors located on the surface of responsive cells.

This interaction promotes the receptor configuration necessary for activation of associated intracellular signaling proteins.

Step 3 – Activation of JAK2–STAT Signaling

Growth hormone receptor activation stimulates JAK2-associated signaling and the phosphorylation of STAT proteins, particularly STAT5.

Activated STAT proteins participate in the regulation of gene expression associated with growth hormone's biological effects.

Step 4 – Stimulation of IGF-1 and Metabolic Pathways

Growth hormone signaling promotes IGF-1 production and influences metabolic processes involving protein synthesis, lipid utilization, and carbohydrate metabolism.

The resulting effects vary among tissues and depend on the physiological and endocrine environment.

Step 5 – Protein Metabolism and Elimination

Somatropin undergoes distribution, receptor-mediated uptake, and proteolytic degradation.

The liver and kidneys contribute to growth hormone clearance, while downstream endocrine effects may persist beyond the period of measurable circulating somatropin.

The circulating elimination half-life of somatropin is relatively short, approximately 20–30 minutes following intravenous administration in commonly cited pharmacokinetic studies.

After subcutaneous administration, the apparent terminal half-life is longer because absorption influences the observed concentration profile. Reported values vary by formulation and study, often falling within a range of several hours.

These pharmacokinetic estimates apply to studied pharmaceutical preparations and should not automatically be applied to an independently unverified formulation.

Somatropin formulations differ from conventional synthetic peptides because they contain a larger, biologically active protein whose molecular structure and stability are essential to receptor activity.

Their formulation characteristics may include:

• Somatropin as the labeled active ingredient.
• A labeled quantity of 16.7 mg per vial.
• A labeled biological activity of 50 IU.
• A recombinant protein containing 191 amino acid residues.
• Structural correspondence to human growth hormone.
• Growth hormone receptor agonist activity.
• Activation of JAK2–STAT-associated intracellular signaling.
• Stimulation of downstream IGF-1 production.
• Lyophilized or liquid presentations, depending on the formulation.
• Excipients selected to support protein stability.
• Sensitivity to temperature, agitation, pH, and protein degradation.
• Packaging and storage requirements determined by the formulation.
• Biological potency and protein purity requiring analytical confirmation.

The precise formulation, excipient composition, and manufacturing specifications of Biochem Somatropin 16.7 mg / 50 IU have not been confirmed.

Formulation ingredients do not independently produce the growth hormone receptor agonist activity associated with somatropin. The stated 50 IU potency is a label claim and should not be interpreted as independently verified biological activity.

United States

Biochem Somatropin 16.7mg, Biochem HGH 50 IU, Biochem Somatropin 50IU USA, Somatropin 16.7mg United States, HGH 50 IU vial, recombinant human growth hormone, rhGH 16.7mg, Somatropin properties, Somatropin description, Somatropin how it works, Somatropin composition, Somatropin pharmacology, Somatropin growth hormone receptor, Somatropin IGF-1 pathway, Somatropin JAK2 STAT signaling, Somatropin protein metabolism, Somatropin lipid metabolism, Somatropin endocrine function, Somatropin mechanism of action, Somatropin molecular structure, human growth hormone 191 amino acids.

Canada

English: Biochem Somatropin 16.7mg Canada, Biochem HGH 50 IU Canada, Somatropin 50IU vial, recombinant human growth hormone Canada, rhGH 16.7mg, Somatropin properties, Somatropin formulation, Somatropin growth hormone receptor, Somatropin IGF-1 signaling, Somatropin endocrine function, Somatropin protein metabolism, Somatropin mechanism of action.

French: Biochem Somatropine 16,7 mg Canada, somatropine 50 UI, hormone de croissance humaine recombinante, HGH 50 UI, flacon somatropine 16,7 mg, propriétés de la somatropine, composition de la somatropine, récepteur de l'hormone de croissance, axe GH IGF-1, métabolisme des protéines, métabolisme lipidique, signalisation JAK2 STAT, mécanisme d'action de la somatropine.

United Kingdom

Biochem Somatropin 16.7mg UK, Biochem HGH 50 IU UK, Somatropin 50IU vial UK, recombinant human growth hormone, rhGH 16.7mg, Somatropin properties, Somatropin pharmacology, Somatropin growth hormone receptor, Somatropin IGF-1 pathway, Somatropin endocrine signalling, Somatropin protein metabolism, Somatropin lipid metabolism, Somatropin molecular composition, Somatropin mechanism of action.

Germany

Biochem Somatropin 16,7 mg Deutschland, Biochem HGH 50 IE, Somatropin 50 IE, rekombinantes menschliches Wachstumshormon, Somatropin 16,7 mg Fläschchen, Somatropin Eigenschaften, Somatropin Wirkungsmechanismus, Somatropin Zusammensetzung, Wachstumshormonrezeptor, GH-IGF-1-Achse, JAK2-STAT-Signalweg, Proteinstoffwechsel, Fettstoffwechsel, endokrine Funktion, Somatropin Proteinstruktur.

France

Biochem Somatropine 16,7 mg France, somatropine 50 UI, hormone de croissance humaine recombinante, HGH 50 UI, flacon somatropine 16,7 mg, propriétés de la somatropine, mécanisme d'action de la somatropine, composition de la somatropine, récepteur de l'hormone de croissance, axe GH IGF-1, signalisation JAK2 STAT, métabolisme des protéines, métabolisme lipidique, fonction endocrinienne, structure de la somatropine.

Spain

Biochem Somatropina 16,7 mg España, somatropina 50 UI, hormona de crecimiento humana recombinante, HGH 50 UI, vial somatropina 16,7 mg, propiedades de la somatropina, cómo funciona la somatropina, composición de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, mecanismo de acción de la somatropina.

Italy

Biochem Somatropina 16,7 mg Italia, somatropina 50 UI, ormone della crescita umano ricombinante, HGH 50 UI, flaconcino somatropina 16,7 mg, proprietà della somatropina, meccanismo d'azione somatropina, composizione della somatropina, recettore dell'ormone della crescita, asse GH IGF-1, segnalazione JAK2 STAT, metabolismo proteico, metabolismo lipidico, funzione endocrina, struttura della somatropina.

Portugal

Biochem Somatropina 16,7 mg Portugal, somatropina 50 UI, hormona de crescimento humana recombinante, HGH 50 UI, frasco somatropina 16,7 mg, propriedades da somatropina, mecanismo de ação somatropina, composição da somatropina, recetor da hormona do crescimento, eixo GH IGF-1, sinalização JAK2 STAT, metabolismo das proteínas, metabolismo lipídico, função endócrina, estrutura da somatropina.

Netherlands

Biochem Somatropine 16,7 mg Nederland, somatropine 50 IE, recombinant menselijk groeihormoon, HGH 50 IE, somatropine 16,7 mg flacon, eigenschappen van somatropine, werkingsmechanisme somatropine, samenstelling van somatropine, groeihormoonreceptor, GH-IGF-1-as, JAK2-STAT-signalering, eiwitmetabolisme, vetmetabolisme, endocriene functie, somatropine eiwitstructuur.

Belgium

Biochem Somatropin 16,7 mg Belgium, Somatropine 50 IE België, somatropine 50 UI Belgique, recombinant groeihormoon, hormone de croissance recombinante, eigenschappen van somatropine, propriétés de la somatropine, groeihormoonreceptor, récepteur de l'hormone de croissance, GH-IGF-1-as, axe GH IGF-1, eiwitmetabolisme, métabolisme des protéines, vetmetabolisme, métabolisme lipidique, JAK2 STAT signalering.

Switzerland

Biochem Somatropin 16,7 mg Switzerland, Somatropin 50 IE Schweiz, somatropine 50 UI Suisse, rekombinantes Wachstumshormon, hormone de croissance recombinante, Somatropin Eigenschaften, propriétés de la somatropine, Wachstumshormonrezeptor, récepteur de l'hormone de croissance, GH-IGF-1-Achse, axe GH IGF-1, Proteinstoffwechsel, métabolisme des protéines, Fettstoffwechsel, métabolisme lipidique, JAK2 STAT.

Austria

Biochem Somatropin 16,7 mg Österreich, Biochem HGH 50 IE, Somatropin 50 IE, rekombinantes menschliches Wachstumshormon, Somatropin 16,7 mg Fläschchen, Somatropin Eigenschaften, Somatropin Wirkungsmechanismus, Wachstumshormonrezeptor, GH-IGF-1-Achse, JAK2-STAT-Signalweg, Proteinstoffwechsel, Fettstoffwechsel, endokrine Funktion, Somatropin Zusammensetzung.

Sweden

Biochem Somatropin 16,7 mg Sverige, somatropin 50 IE, rekombinant humant tillväxthormon, HGH 50 IE, somatropin 16,7 mg injektionsflaska, somatropin egenskaper, somatropin verkningsmekanism, tillväxthormonreceptor, GH-IGF-1-axeln, JAK2-STAT-signalering, proteinmetabolism, fettmetabolism, endokrin funktion, somatropin proteinstruktur.

Norway

Biochem Somatropin 16,7 mg Norge, somatropin 50 IE, rekombinant humant veksthormon, HGH 50 IE, somatropin 16,7 mg hetteglass, somatropin egenskaper, somatropin virkningsmekanisme, veksthormonreseptor, GH-IGF-1-aksen, JAK2-STAT-signalering, proteinmetabolisme, fettmetabolisme, endokrin funksjon, somatropin proteinstruktur.

Denmark

Biochem Somatropin 16,7 mg Danmark, somatropin 50 IE, rekombinant humant væksthormon, HGH 50 IE, somatropin 16,7 mg hætteglas, somatropin egenskaber, somatropin virkningsmekanisme, væksthormonreceptor, GH-IGF-1-aksen, JAK2-STAT-signalering, proteinmetabolisme, fedtmetabolisme, endokrin funktion, somatropin proteinstruktur.

Finland

Biochem Somatropin 16,7 mg Suomi, somatropiini 50 IU, rekombinantti ihmisen kasvuhormoni, HGH 50 IU, somatropiini 16,7 mg injektiopullo, somatropiinin ominaisuudet, somatropiinin vaikutusmekanismi, kasvuhormonireseptori, GH-IGF-1-akseli, JAK2-STAT-signalointi, proteiiniaineenvaihdunta, rasva-aineenvaihdunta, hormonitoiminta, somatropiinin proteiinirakenne.

Poland

Biochem Somatropin 16,7 mg Polska, somatropina 50 IU, rekombinowany ludzki hormon wzrostu, HGH 50 IU, fiolka somatropina 16,7 mg, właściwości somatropiny, mechanizm działania somatropiny, skład somatropiny, receptor hormonu wzrostu, oś GH IGF-1, sygnalizacja JAK2 STAT, metabolizm białek, metabolizm tłuszczów, funkcja hormonalna, struktura białka somatropina.

Czech Republic

Biochem Somatropin 16,7 mg Česko, somatropin 50 IU, rekombinantní lidský růstový hormon, HGH 50 IU, lahvička somatropin 16,7 mg, vlastnosti somatropinu, mechanismus účinku somatropinu, složení somatropinu, receptor růstového hormonu, osa GH IGF-1, signalizace JAK2 STAT, metabolismus bílkovin, metabolismus tuků, endokrinní funkce, struktura proteinu somatropin.

Romania

Biochem Somatropin 16,7 mg România, somatropină 50 UI, hormon de creștere uman recombinant, HGH 50 UI, flacon somatropină 16,7 mg, proprietăți somatropină, mecanism de acțiune somatropină, compoziția somatropinei, receptorul hormonului de creștere, axa GH IGF-1, semnalizare JAK2 STAT, metabolismul proteinelor, metabolismul lipidelor, funcție endocrină, structura somatropinei.

Greece

Biochem Somatropin 16,7 mg Ελλάδα, σωματροπίνη 50 IU, ανασυνδυασμένη ανθρώπινη αυξητική ορμόνη, HGH 50 IU, φιαλίδιο σωματροπίνης 16,7 mg, ιδιότητες σωματροπίνης, μηχανισμός δράσης σωματροπίνης, σύνθεση σωματροπίνης, υποδοχέας αυξητικής ορμόνης, άξονας GH IGF-1, σηματοδότηση JAK2 STAT, μεταβολισμός πρωτεϊνών, μεταβολισμός λιπιδίων, ενδοκρινική λειτουργία, δομή πρωτεΐνης σωματροπίνης.

Ireland

Biochem Somatropin 16.7mg Ireland, Biochem HGH 50 IU Ireland, Somatropin 50IU vial Ireland, recombinant human growth hormone, rhGH 16.7mg, Somatropin properties, Somatropin pharmacology, Somatropin growth hormone receptor, Somatropin IGF-1 pathway, Somatropin endocrine signalling, Somatropin protein metabolism, Somatropin lipid metabolism, Somatropin molecular composition, Somatropin mechanism of action.

Colombia

Biochem Somatropina 16,7 mg Colombia, somatropina 50 UI Colombia, HGH 50 UI, hormona de crecimiento humana recombinante, vial somatropina 16,7 mg, propiedades de la somatropina, cómo funciona la somatropina, farmacología de la somatropina, composición de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, mecanismo de acción de la somatropina, descripción de la somatropina.

Argentina

Biochem Somatropina 16,7 mg Argentina, somatropina 50 UI Argentina, HGH 50 UI, hormona de crecimiento humana recombinante, vial somatropina 16,7 mg, propiedades de la somatropina, qué es la somatropina, cómo actúa la somatropina, farmacología de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, composición de la somatropina.

México

Biochem Somatropina 16,7 mg México, somatropina 50 UI México, HGH 50 UI, hormona de crecimiento humana recombinante, vial somatropina 16,7 mg, propiedades de la somatropina, para qué se utiliza la somatropina, cómo funciona la somatropina, farmacología de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, mecanismo de acción de la somatropina.

Perú

Biochem Somatropina 16,7 mg Perú, somatropina 50 UI Perú, HGH 50 UI, hormona de crecimiento humana recombinante, vial somatropina 16,7 mg, propiedades de la somatropina, qué es la somatropina, cómo funciona la somatropina, farmacología de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, composición de la somatropina.

Venezuela

Biochem Somatropina 16,7 mg Venezuela, somatropina 50 UI Venezuela, HGH 50 UI, hormona de crecimiento humana recombinante, vial somatropina 16,7 mg, propiedades de la somatropina, qué es la somatropina, cómo actúa la somatropina, farmacología de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, composición de la somatropina.

Ecuador

Biochem Somatropina 16,7 mg Ecuador, somatropina 50 UI Ecuador, HGH 50 UI, hormona de crecimiento humana recombinante, vial somatropina 16,7 mg, propiedades de la somatropina, para qué se utiliza la somatropina, cómo funciona la somatropina, farmacología de la somatropina, receptor de hormona de crecimiento, eje GH IGF-1, señalización JAK2 STAT, metabolismo de proteínas, metabolismo de grasas, función endocrina, composición de la somatropina, mecanismo de acción de la somatropina, descripción de la somatropina.

Biochem Somatropin 16.7mg / 50 IU | Recombinant Human Growth Hormone

Learn about Biochem Somatropin 16.7mg / 50 IU, a recombinant human growth hormone associated with growth hormone receptor activation, IGF-1 production, and endocrine metabolic regulation.

Biochem Somatropina 16,7mg / 50 UI | Hormona de Crecimiento Humana

Conoce Biochem Somatropina 16,7mg / 50 UI, una hormona de crecimiento humana recombinante relacionada con la activación del receptor GH, la producción de IGF-1 y la regulación metabólica endocrina.

biochem-somatropin-hgh-16-7mg-50iu-human-growth-hormone

biochem-somatropina-hgh-16-7mg-50ui-hormona-crecimiento

Biochem Somatropin HGH 16.7mg / 50 IU vial labeled as containing recombinant human growth hormone, a 191-amino-acid protein associated with growth hormone receptor activation, IGF-1 signaling, and endocrine metabolic regulation.

Biochem Somatropina HGH 16,7mg / 50 UI vial etiquetado como hormona de crecimiento humana recombinante, una proteína de 191 aminoácidos relacionada con la activación del receptor GH, la señalización IGF-1 y la regulación metabólica endocrina.